It's a good day to be CVS, as the pharmacy giant officially announced its planned $10.6 billion acquisition of Oak Street Health and beat Q4 earnings estimates.
Why it matters: CVS has not one but two deals now pending, valued at a combined total of $18.5 billion, and it's already getting antitrust pushback.
